On January 3, 2018 PTC Therapeutics, Inc. (NASDAQ: PTCT) reported that the company will present a company overview at the upcoming 36th Annual JP Morgan Healthcare Conference on Wednesday, January 10th at 2:30 pm PT (Press release, PTC Therapeutics, JAN 3, 2018, View Source [SID1234522836]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics’ website at www.ptcbio.com. The presentation will be archived for two weeks following the presentation. It is recommended that users connect to PTC’s website several minutes prior to the start of the webcast to ensure a timely connection.

On January 3, 2018 Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) reported that Dave Stack, chief executive officer and chairman of Pacira Pharmaceuticals, Inc. is scheduled to present at the 36th Annual J.P. Morgan Healthcare Conference at 2:00 PM PT (5:00 PM ET) on Tuesday, January 9, 2018 in San Francisco, CA (Press release, Pacira Pharmaceuticals, JAN 3, 2018, View Source;p=RssLanding&cat=news&id=2324594 [SID1234522835]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast of the Pacira presentation can be accessed by visiting the "Investors & Media" section of the company’s website at investor.pacira.com. A replay of the webcast will be archived on the Pacira website for two weeks following the presentation date.

On January 3, 2018 Merck (NYSE: MRK), known as MSD outside the United States and Canada, reported that it will hold its fourth-quarter and full-year 2017 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EST on Friday, February 2 (Press release, Merck & Co, JAN 3, 2018, View Source [SID1234522834]). During the call, company executives will provide an overview of Merck’s performance for the quarter and year.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Investors, journalists and the general public may access a live audio webcast of the call on Merck’s website at View Source A replay of the webcast, along with the sales and earnings news release and supplemental financial disclosures, will be available at www.merck.com.

Institutional investors and analysts can participate in the call by dialing (706) 758-9927 or (877) 381-5782 and using ID code number 9899537. Members of the media are invited to monitor the call by dialing (706) 758-9928 or (800) 399-7917 and using ID code number 9899537. Journalists who wish to ask questions are requested to contact a member of Merck’s Media Relations team at the conclusion of the call.

On January 3, 2018 INSYS Therapeutics, Inc. (NASDAQ:INSY), reported that Saeed Motahari, president and chief executive officer, and Andrew Long, chief financial officer, will present at the 36th annual J.P. Morgan Healthcare Conference as follows(Press release, Insys Therapeutics, JAN 3, 2018, View Source;p=RssLanding&cat=news&id=2324652 [SID1234522833]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Date: Thursday, Jan. 11, 2018
Time: 7:30 a.m. Pacific Standard Time
Location: San Francisco – Westin St. Francis Hotel
The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Investors section of company’s website at View Source, under Presentations & Events. The presentation slides will be available during the conference, accessible at the same webpage.

In addition to making a presentation, management will also provide an overview of the company’s business in one-on-one meetings with investors who are registered to attend the conference.

On January 3, 2018 Celgene Corporation (NASDAQ: CELG) reported that it will host a conference call and live audio webcast on Thursday, January 25, 2018 at 9 a.m. ET to discuss fourth quarter and full-year 2017 financial and operational results (Press release, Celgene, JAN 3, 2018, View Source [SID1234522832]). The webcast can be accessed from the Investor Relations page at www.celgene.com.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!